Harold A. Sackeim is an American psychologist and electroconvulsive therapy researcher.
[3] Sackheim has consulted for MECTA and Somatics, companies that manufacture devices for its administration, with payments going to his lab instead of to himself personally.
[4] In 2007, Sackeim and his colleagues published the results of a study which followed 250 patients who had received electroconvulsive therapy.
The study found that the various techniques used when giving electroconvulsive therapy can have a direct impact on the adverse effects experienced by patients.
Sackeim and colleagues later demonstrated that right unilateral electroconvulsive therapy with an ultra brief pulse appears to be the most efficacious, while remaining the least likely to cause adverse effects.